Literature DB >> 20128794

Clinical guidelines for testing for heritable thrombophilia.

Trevor Baglin1, Elaine Gray, Mike Greaves, Beverley J Hunt, David Keeling, Sam Machin, Ian Mackie, Mike Makris, Tim Nokes, David Perry, R C Tait, Isobel Walker, Henry Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20128794     DOI： 10.1111/j.1365-2141.2009.08022.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  69 in total

1.  Evaluation of GenoFlow Thrombophilia Array Test Kit in its detection of mutations in Factor V Leiden (G1691A), prothrombin G20210A, MTHFR C677T and A1298C in blood samples from 113 Turkish female patients.

Authors:  Ebru Aytekin; Sezen Guntekin Ergun; Mehmet Ali Ergun; Ferda E Percin
Journal:  Genet Test Mol Biomarkers       Date:  2014-08-25

Review 2.  Thrombophilia: clinical-practical aspects.

Authors:  Stephan Moll
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

3.  Utility of thrombophilia testing in patients with venous thrombo-embolism.

Authors:  Masataka Kudo; Huang L Lee; Ian A Yang; Philip J Masel
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

4.  Unusual venous thrombosis in a 35-year-old man.

Authors:  Ami Schattner
Journal:  CMAJ       Date:  2013-10-28       Impact factor: 8.262

Review 5.  Role of thrombophilia testing: con.

Authors:  Scott M Stevens
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

6.  Saddle pulmonary embolism as the initial presentation of prothrombin gene mutation G20210A.

Authors:  Amirali Kiyani; Shannon Ursu
Journal:  BMJ Case Rep       Date:  2016-12-02

7.  Low-Value Service Use in Provider Organizations.

Authors:  Aaron L Schwartz; Alan M Zaslavsky; Bruce E Landon; Michael E Chernew; J Michael McWilliams
Journal:  Health Serv Res       Date:  2016-11-10       Impact factor: 3.402

8.  Non-O blood group: an important genetic risk factor for venous thromboembolism.

Authors:  Massimo Franchini; Mike Makris
Journal:  Blood Transfus       Date:  2012-10-11       Impact factor: 3.443

9.  Measuring low-value care in Medicare.

Authors:  Aaron L Schwartz; Bruce E Landon; Adam G Elshaug; Michael E Chernew; J Michael McWilliams
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

10.  Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study.

Authors:  Maurizio Margaglione; Emilia Antonucci; Giovanna D'Andrea; Ludovica Migliaccio; Walter Ageno; Eugenio Bucherini; Benilde Cosmi; Anna Falanga; Giuliana Martini; Daniela Mastroiacovo; Carmelo Paparo; Daniela Poli; Sophie Testa; Gualtiero Palareti
Journal:  Blood Transfus       Date:  2020-09-18       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.